SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001113148-21-000002
Filing Date
2021-01-06
Accepted
2021-01-06 09:17:13
Documents
16
Period of Report
2021-01-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K infi-20210106.htm   iXBRL 8-K 42929
7 GRAPHIC headera031.jpg GRAPHIC 24003
8 EX-99.1 mario275updatepressrelease.htm EX-99.1 21204
  Complete submission text file 0001113148-21-000002.txt   250009

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20210106.xsd EX-101.SCH 2411
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20210106_cal.xml EX-101.CAL 702
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20210106_def.xml EX-101.DEF 1635
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20210106_lab.xml EX-101.LAB 24993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20210106_pre.xml EX-101.PRE 13182
9 EXTRACTED XBRL INSTANCE DOCUMENT infi-20210106_htm.xml XML 11513
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 21509175
SIC: 2834 Pharmaceutical Preparations